Identification of deregulation in protein expression level of erlotinib-resistant H1299 cell lines

Erlotinib, a small-molecule epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor, has been shown to be an effective solution in treating non-small cell lung cancer (NSCLC). However, most patients who initially show a good response to erlotinib treatment eventually develop resistant and...

Full description

Bibliographic Details
Main Author: Mat Daud, Syukriyah
Format: Project Paper Report
Language:English
Published: 2015
Online Access:http://psasir.upm.edu.my/id/eprint/91013/
http://psasir.upm.edu.my/id/eprint/91013/1/FBSB%202015%20132%20-%20IR.pdf
_version_ 1848861228243353600
author Mat Daud, Syukriyah
author_facet Mat Daud, Syukriyah
author_sort Mat Daud, Syukriyah
building UPM Institutional Repository
collection Online Access
description Erlotinib, a small-molecule epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor, has been shown to be an effective solution in treating non-small cell lung cancer (NSCLC). However, most patients who initially show a good response to erlotinib treatment eventually develop resistant and experience progressive disease. There is no absolute answer on how the cells can develop resistance against the erlotinib. It was suggested that changes in the cell cycle could contribute to the acquired resistance of NSCLC. In this study, untreated H1299 and erlotinib-resistant H1299 (H1299-R) were used to compare proteins expression levels involved in cell cycle. The main cell cycle players that were investigated included Cyclin A and E, Cyclin-dependent kinases (CDK) 2, 4, and 6, p21, NFKB, and ß-actin. A calourimetric method, alkaline phosphatase, was used to detect the amount of proteins present in the sample. Although the concentration of the protein loaded into the gel was increased from 75 μg to 85 μg, the results obtained were similar. Both cell lines possessed ß-actin and Cyclin A proteins only.
first_indexed 2025-11-15T12:57:47Z
format Project Paper Report
id upm-91013
institution Universiti Putra Malaysia
institution_category Local University
language English
last_indexed 2025-11-15T12:57:47Z
publishDate 2015
recordtype eprints
repository_type Digital Repository
spelling upm-910132021-10-18T01:35:06Z http://psasir.upm.edu.my/id/eprint/91013/ Identification of deregulation in protein expression level of erlotinib-resistant H1299 cell lines Mat Daud, Syukriyah Erlotinib, a small-molecule epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor, has been shown to be an effective solution in treating non-small cell lung cancer (NSCLC). However, most patients who initially show a good response to erlotinib treatment eventually develop resistant and experience progressive disease. There is no absolute answer on how the cells can develop resistance against the erlotinib. It was suggested that changes in the cell cycle could contribute to the acquired resistance of NSCLC. In this study, untreated H1299 and erlotinib-resistant H1299 (H1299-R) were used to compare proteins expression levels involved in cell cycle. The main cell cycle players that were investigated included Cyclin A and E, Cyclin-dependent kinases (CDK) 2, 4, and 6, p21, NFKB, and ß-actin. A calourimetric method, alkaline phosphatase, was used to detect the amount of proteins present in the sample. Although the concentration of the protein loaded into the gel was increased from 75 μg to 85 μg, the results obtained were similar. Both cell lines possessed ß-actin and Cyclin A proteins only. 2015 Project Paper Report NonPeerReviewed text en http://psasir.upm.edu.my/id/eprint/91013/1/FBSB%202015%20132%20-%20IR.pdf Mat Daud, Syukriyah (2015) Identification of deregulation in protein expression level of erlotinib-resistant H1299 cell lines. [Project Paper Report]
spellingShingle Mat Daud, Syukriyah
Identification of deregulation in protein expression level of erlotinib-resistant H1299 cell lines
title Identification of deregulation in protein expression level of erlotinib-resistant H1299 cell lines
title_full Identification of deregulation in protein expression level of erlotinib-resistant H1299 cell lines
title_fullStr Identification of deregulation in protein expression level of erlotinib-resistant H1299 cell lines
title_full_unstemmed Identification of deregulation in protein expression level of erlotinib-resistant H1299 cell lines
title_short Identification of deregulation in protein expression level of erlotinib-resistant H1299 cell lines
title_sort identification of deregulation in protein expression level of erlotinib-resistant h1299 cell lines
url http://psasir.upm.edu.my/id/eprint/91013/
http://psasir.upm.edu.my/id/eprint/91013/1/FBSB%202015%20132%20-%20IR.pdf